162 related articles for article (PubMed ID: 38014605)
1. Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study.
Manti S; Giallongo A; Parisi GF; Papale M; Mulè E; Aloisio D; Rotolo N; Leonardi S
Pediatr Pulmonol; 2024 Mar; 59(3):801-804. PubMed ID: 38014605
[No Abstract] [Full Text] [Related]
2. Pharmacogenetics of cystic fibrosis treatment.
Carter SC; McKone EF
Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
[TBL] [Abstract][Full Text] [Related]
3. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis.
Derichs N
Eur Respir Rev; 2013 Mar; 22(127):58-65. PubMed ID: 23457166
[TBL] [Abstract][Full Text] [Related]
4. Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis.
Cuyx S; De Boeck K
Semin Respir Crit Care Med; 2019 Dec; 40(6):762-774. PubMed ID: 31659727
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.
Solomon GM; Marshall SG; Ramsey BW; Rowe SM
Pediatr Pulmonol; 2015 Oct; 50 Suppl 40(0 40):S3-S13. PubMed ID: 26097168
[TBL] [Abstract][Full Text] [Related]
6. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.
Lee SE; Farzal Z; Daniels MLA; Thorp BD; Zanation AM; Senior BA; Ebert CS; Kimple AJ
Am J Rhinol Allergy; 2020 Jul; 34(4):573-580. PubMed ID: 32168995
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis: CFTR modulators and their mechanism of action.
Nieddu E
Curr Pharm Des; 2013; 19(19):3474-5. PubMed ID: 23331031
[No Abstract] [Full Text] [Related]
8. Current state of CFTR modulators for treatment of Cystic Fibrosis.
Despotes KA; Donaldson SH
Curr Opin Pharmacol; 2022 Aug; 65():102239. PubMed ID: 35609385
[TBL] [Abstract][Full Text] [Related]
9. Cystic Fibrosis in the Era of Highly Effective CFTR Modulators.
Britto CJ; Taylor-Cousar JL
Clin Chest Med; 2022 Dec; 43(4):xiii-xvi. PubMed ID: 36344084
[No Abstract] [Full Text] [Related]
10. Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis.
McGarry ME; Gibb ER; Oates GR; Schechter MS
Paediatr Respir Rev; 2022 Jun; 42():35-42. PubMed ID: 35277357
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators.
Fajac I; Sermet-Gaudelus I
Curr Opin Pulm Med; 2021 Nov; 27(6):567-574. PubMed ID: 34494979
[TBL] [Abstract][Full Text] [Related]
12. F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.
Yang H; Ma T
Expert Opin Ther Pat; 2015; 25(9):991-1002. PubMed ID: 25971311
[TBL] [Abstract][Full Text] [Related]
13. Pulmonology: CFTR modulators for cystic fibrosis.
Bertoncini E; Colomb-Lippa D
JAAPA; 2013 Feb; 26(2):59-60. PubMed ID: 23409389
[No Abstract] [Full Text] [Related]
14. Advancing clinical development pathways for new CFTR modulators in cystic fibrosis.
Mayer-Hamblett N; Boyle M; VanDevanter D
Thorax; 2016 May; 71(5):454-61. PubMed ID: 26903594
[TBL] [Abstract][Full Text] [Related]
15. Understanding CFTR Functionality: A Comprehensive Review of Tests and Modulator Therapy in Cystic Fibrosis.
Thakur S; Ankita ; Dash S; Verma R; Kaur C; Kumar R; Mazumder A; Singh G
Cell Biochem Biophys; 2024 Mar; 82(1):15-34. PubMed ID: 38048024
[TBL] [Abstract][Full Text] [Related]
16. CFTR mutations and cystic fibrosis.
Prescrire Int; 2013 Oct; 22(142):232. PubMed ID: 24298580
[No Abstract] [Full Text] [Related]
17. New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator.
Ong T; Ramsey BW
Pediatr Clin North Am; 2016 Aug; 63(4):751-64. PubMed ID: 27469186
[TBL] [Abstract][Full Text] [Related]
18. CFTR Modulators for the Gastroenterologist.
Sabharwal S; Lusman SS
J Pediatr Gastroenterol Nutr; 2023 Oct; 77(4):445-447. PubMed ID: 37548477
[No Abstract] [Full Text] [Related]
19. Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis.
Burgener EB; Moss RB
Curr Opin Pediatr; 2018 Jun; 30(3):372-377. PubMed ID: 29538046
[TBL] [Abstract][Full Text] [Related]
20. The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis.
Sergeev V; Chou FY; Lam GY; Hamilton CM; Wilcox PG; Quon BS
Ann Am Thorac Soc; 2020 Feb; 17(2):147-154. PubMed ID: 31661636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
